We are live on ! Find out more
TM

Triatomic Management Portfolio holdings

AUM $3.39M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
-19.01%
1 Year Est. Return
-3.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.39M
AUM Growth
-$50.2M
Cap. Flow
-$3.62M
Cap. Flow %
-106.88%
Top 10 Hldgs %
100%
Holding
27
New
2
Increased
1
Reduced
3
Closed
19
Avg Time Held Equity + Options
5.9 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.5 quarters
Avg Time Held Equity only
5.9 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
3.3 quarters

Top Buys

Rank Stock Value
1
W icon
Wayfair
W
+$891K
2
MRNA icon
Moderna
MRNA
+$664K
3
AGNT icon
AGNT Inc
AGNT
+$223K

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$1.14M
2
BEKE icon
KE Holdings
BEKE
+$1.07M
3
META icon
Meta Platforms (Facebook)
META
+$983K
4
BABA icon
Alibaba
BABA
+$606K
5
IOT icon
Samsara
IOT
+$449K

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.82%
2 Healthcare 31.11%
3 Consumer Discretionary 23.33%
4 Real Estate 11.72%
5 Miscellaneous 0.03%

No holdings matched the selected filter criteria.

Similar funds

Triatomic Management's Q2 2024 Portfolio in Review

As of Q2 2024, Triatomic Management held 27 positions worth $3.39M, down 94% from $53.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Triatomic Management withdrew a net $3.62M in Q2 2024, closing 19 positions and reducing 3 holdings. Its most notable exit was Pinduoduo, an estimated $1.14M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 34% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Triatomic Management opened a new position in Wayfair worth $791K.

  • Triatomic Management's largest Q2 2024 buy was Wayfair: 15,000 shares worth $791K.
  • Triatomic Management added most to AGNT Inc in Q2 2024, an estimated $223K increase.
  • Triatomic Management's biggest Q2 2024 reduction was Senti Biosciences Holdings, cutting an estimated $95.6K.
  • Triatomic Management fully exited Pinduoduo in Q2 2024, selling an estimated $1.14M.
  • Triatomic Management's ten largest holdings make up 100% of its $3.39M portfolio in Q2 2024.
  • Triatomic Management opened 2 new positions and closed 19 in Q2 2024.
  • Triatomic Management's portfolio value fell 94% quarter-over-quarter to $3.39M.

Based on Triatomic Management's 13F filing for Q2 2024, filed 14 Aug 2024.